<DOC>
	<DOCNO>NCT02041663</DOCNO>
	<brief_summary>Use brain natriuretic peptide evaluate cardiac function course meningococcal septic shock severe sepsis .</brief_summary>
	<brief_title>Septic cArdiac Deficiency MenIngococcal seveRe Sepsis</brief_title>
	<detailed_description>OBJECTIVES : determine sensibility specificity BNP blood level detect myocardial dysfunction septic shock severe sepsis due Neisseria meningitidis child . METHODS : Prospective multicentric clinical trial include 7 French pediatric intensive care unit . Serial cardiac ultra sound blood sample do patient hospitalize purpura fulminans begin time admission pediatric intensive care . Any child 6 month 18 year without preexist cardiac disease present purpura fulminans enrol obtain consent parent . From adult 's study septic shock BNP , total number 30 patient calculate necessary prove interest BNP indication .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Children 6 month 18 year age without previous cardiac pathology hospitalize participate pediatric intensive care unit serious sepsis extensive purpura Heart malformative disorder rightleft shunt Preexistent know cardiac insufficiency whatever origin Concomitant participation another trial Patient period exclusion another trial Not membership national insurance scheme</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>brain natriuretic peptide</keyword>
	<keyword>cardiac function</keyword>
	<keyword>meningococcal infection</keyword>
	<keyword>septic shock</keyword>
	<keyword>severe sepsis</keyword>
</DOC>